{
  "docId": "019de070-d3cd-70da-8da9-11fac56c0e6a",
  "docSlug": "a10c554cbe4a4cf1ea91fc4610f64010",
  "documentTitle": "NeuroBo Pharmaceuticals | Investor Presentation Deck | 27 slides",
  "authorId": "neurobo-pharmaceuticals",
  "authorName": "NeuroBo Pharmaceuticals",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 17,
  "pageCount": 27,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": "competitive_analysis",
  "function": "compare_peers",
  "density": "balanced",
  "nDataPoints": 70,
  "notes": "The table lists 10 distinct clinical trial entries.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-d3cd-70da-8da9-11fac56c0e6a/17",
  "deckHref": "/decks/019de070-d3cd-70da-8da9-11fac56c0e6a",
  "deckJsonHref": "/decks/019de070-d3cd-70da-8da9-11fac56c0e6a.json",
  "deckAnchorHref": "/decks/019de070-d3cd-70da-8da9-11fac56c0e6a#slide-17",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.1,
        "y": 0.85
      },
      "kind": "subtitle",
      "text": "10 Active COVID Programs for Niclosamide Trials on U.S. and EU databases—ClinicalTrials.gov",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6dd2b0c6-7689-46cd-be7d-7b0260b4e30b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.9,
        "x": 0.05,
        "y": 0.33
      },
      "kind": "table",
      "text": "Table of clinical trials including Company Name, NCT, Phase, Start, End, Formulation, Sites, and N.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1215e737-31a0-4ea6-b2d3-228e17900bdb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "title",
      "text": "We believe NRBO is the lead program to NDA for niclosamide capsule formulation in the U.S.",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "29d41d29-2549-464c-b26b-d3694394cbe0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.6,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Competitive Activity in Clinical Development for Niclosamide",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2350a6ad-6656-43a3-8c31-37b2f6d747d5",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}